Congratulations Dr. Gaelen Guzman!
It’s official! Gaelen Guzman has earned his PhD and is now a postdoctoral scholar!
His dissertation can be read here. (Embargoed until May 2025.)
Mila performed with vocal ensemble Radix!
Congratulations Dr. Scotland Farley!
Scotty Farley has also advanced from PhD to postdoctoral scholar!
Here is a link to his dissertation. (Embargoed until June 2026.)
Congratulations Dr. Tim Bates!
Tim Bates has advanced from PhD student to postdoctoral scholar!
His dissertation presentation can be watched here.
Tim also received the John A. Resko Outstanding Doctoral Dissertation Award!
His dissertation can be read here.
Paper of the Year!
So delighted to learn that our article that describes how SARS-CoV-2 hijacks lipid metabolism pathways has been selected as Paper of the Year by NIH NIEHS.
Our paper that describes a potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants is now published in iScience.
So excited to share our new study that is published at JAMA. We show that the immune response of the Pfizer COVID-19 vaccine is age-dependent. Thanks to our collaborators: the Curlin lab and the Messer lab.
High-level recognition for our research!
Dr. Anthony Fauci, chief medical advisor to President Joe Biden, shared our findings that show people previously infected with the novel coronavirus stand to get a much greater benefit of protection against new variants if they’re vaccinated. Watch the White House briefing from May 5 (our work is discussed at minute 14:14).
In collaboration with the lab of Eric Barklis, we published a new study in the Virology Journal. We showed that nanobodies that bind the HIV-1 Capsid protein block viral assembly and infectivity. Our findings demonstrate the feasibility of targeting HIV proteins, including the Gag/Capsid, with nanobodies to inhibit HIV-1 infection.
Our pre-print that shows the escape of SARS-CoV-2 variants (UK/B.1.1.7 and South Africa/B.1.351) from humoral immunity elicited by vaccine and natural infections is now in medRxiv.
Our pre-print that shows previously infected vaccinees broadly neutralize SARS-CoV-2 variants of concern is now in medRxiv.
As discussed in this OHSU Research News publication, our lab was able to shift gears from TB to COVID-19 (thanks to the flexibility of alpaca antibodies) when the arrival of pandemic necessitated this change of focus.
In conjunction with our paper on Zika virus's infection mechanism in Nature Communications, we posted additional information about this master membrane manipulator on Nature Community's "Behind the paper" blog.
Our paper that describes the role of Sphingolipids in the entry of M. tuberculosis is now accepted for publication in mBio. See the accepted manuscript in bioRxiv.